JUN 05, 2019 05:01 PM PDT

Additional drug in hormone therapy for breast cancer extends women's lives

The findings from a new clinical trial were presented this week at the American Society of Clinical Oncology annual meeting in Chicago. The trial showed that the addition of a drug called Kisqali (ribociclib) to standard hormone therapy has the capability of lengthening the lives of younger women with advanced breast cancer. The trial’s findings will be published in the New England Journal of Medicine.

The trial was led by Dr. Debu Tripathy, chair of the breast medical oncology department at M.D. Anderson Cancer Center in Houston. All of the women participating in the trial received standard hormonal therapy, in addition to a medication that turns off the ovaries' production of estrogen. Dr. Tripathy’s team also gave half of the women Kisqali and half a placebo.

Kisqali is taken as a tablet and is in a class of drugs called CDK4/6 inhibitors; it functions by blocking two proteins that help cancer cells grow and divide.

The trial found that on average, the women who received Kisqali lived six months longer than women in the control group. After 3.5 years, 70% of patients given hormone therapy plus Kisqali were still alive, compared to 46% of those given hormone therapy alone.

"In reality, what this means is if we get a confirmation from the bigger trial, then this could well lead to a change in the standard of care across the world,” said Dr. Rob Jones, trial co-leader and a consultant in oncology. "When you're given a diagnosis of cancer that is incurable, any extension of life is incredibly important," he added. "We've talked about averages but there are plenty of examples in the trial of patients who have lived for two or three years without their disease yet progressing."

Kisqali could extend the lives of women with advanced breast cancer. Photo: Pixabay

The researchers hope that this trial will provide enough evidence to make significant changes in the standard of care offered to premenopausal women with advanced breast cancer. They hope it will extend worldwide.

Sources: BBC, CBS News

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 17, 2020
Health & Medicine
JAN 17, 2020
Breast Cancer - Key Facts & Figures
Did you know one in eight women will be diagnosed with breast cancer in her lifetime? October is Breast Cancer Awareness month, and we are raising awareness of one of the most common types of...
JAN 17, 2020
Cancer
JAN 17, 2020
Hair follicles: an origin point for melanoma
As far as skin cancers go, advanced invasive melanoma is quite aggressive – treatment options are still lacking effectiveness. Even though it is quit...
JAN 17, 2020
Cancer
JAN 17, 2020
Specific gut bacteria linked to bowel cancer
New research suggests that the presence of a certain kind of gut bacteria can increase the risk of bowel cancer by as much as 15%. The research is importan...
JAN 17, 2020
Cancer
JAN 17, 2020
Using deep learning to find the patterns of cancer
Research published recently in the journal Life Science Alliance uses deep learning to analyze genomic data from colorectal tumors to ameliorate diagnosis ...
JAN 17, 2020
Drug Discovery & Development
JAN 17, 2020
Can Cancer Drugs Treat Lung Damage?
Can therapeutics used in the treatment of cancer be a breakthrough for pulmonary disease? Specifically, chronic obstructive pulmonary disease (COPD)? &ldqu...
JAN 17, 2020
Cancer
JAN 17, 2020
Could the flu vaccine shrink cancer tumors?
If you’ve been to the doctor recently, you’ve probably been asked if you want a flu shot this year. The flu vaccine is popular because it reduc...
Loading Comments...